Introduction: Two healthcare
companies in the U.S have implemented using block chain technology to better
understand and record gene sequences and appealed to create a new academic
research field – life data economics. The companies are Nebula Genomics and
Longenisis, both are firms working in Artificial Intelligence and Block chain
technology for healthcare. Based on healthcare
industry research and market reports
these companies implement the usage of block chain technology for creation of a
platform for management and trading of medical information on block chain data
allowing their users to profit from their genomic and other types of clinical
data. Nebula Genomics and Longenesis say that their work will establish two new
fields. The first, “microdataeconomics,” is “the study of the value of life
data that is used for drug discovery such as proteomics or data regarding the
structure and activity of specific molecules, both in vitro and in vivo.” The
second, “macrodataeconomics,” is “the study of the value of life data that is
used to determine human health such as electronic health records and genomics.
Genomics: NHGRI defines
genomic medicine as "an emerging medical discipline that involves using
genomic information about an individual as part of their clinical care (e.g.,
for diagnostic or therapeutic decision-making) and the health outcomes and
policy implications of that clinical use." Already, genomic medicine is
making an impact in the fields of oncology, pharmacology, rare and undiagnosed
diseases, and infectious disease. Genomics
is a field of modern medicine that applies a patient’s genetic makeup to
understand their body composition, further understand their medical structure
and to personalize their treatment. The science works using the structure,
mapping, and analysis of an organism’s genome, which is the complete makeup of
their DNA. The field has so far been limited to genetics but is having
increasing application in the field of health care and medicine by increasing
the scope for personalized medical treatment for patients. Genomics is already
driving a remarkable paradigm shift in health. In the last 15 years, the cost
of reading an individual's DNA sequence has plummeted from hundreds of millions
of dollars to around a few hundred to a few thousand dollars. Applications of
genomics in cancer, rare disease and reproductive services are booming, with
other clinical areas set to follow suit. In addition, joint ventures, mergers
and R&D agreements relating to genomic technologies have grown
exponentially in the past decade.
LDE: Life Data Economics
is an experimental research field that applies block chain and heavy sets of
patient lifestyle data to gauge the medical condition of the patient and further
reveal trends that have led to specific diseases and conditions. The science
has been petitioned to be made official by Nebula Genomics and if successful
would allow for block chain health care providers to use artificial
intelligence to not only record all aspects of a patient’s health, but also to
analyze health and discover causes that were previously unknown to medical
professionals. The application of Life Data Economics is that it also helps
understand the extent of impact that a person’s lifestyle has on their physical
health and well being.
Conclusion: The application of
Life Data Economics is genuinely new, with the technology not even officially
being in the introductory phase. But the potential the technology has presented
is a game changer for the field of healthcare, medicine and IoT based
healthcare. Not only is this a technology capable of tracking and understanding
a patient and their lifestyle, but with enough time and data, and integration
of artificial intelligence, the usage of genomic based LDE could lead to
discoveries in medicine which were not possible before to know based on factors
for disease and the type of medicine that would be more effective occurring at
a rapid rate. The implementation of technology has had a major impact on the
growth of almost every sector in the world. The future of industry is
integration with the internet, the remaining aspect is the rate of adoption as
the technology is still to be experimented and proven. As earlier, the time
between researching an innovation and implementing it as a clinical practice
was about 17 years, the rapid growth and increased investment into research and
development, especially in the sector of medicine has shortened that time
significantly allowing for companies to figure out better, safer methods to
help with the health of patients as well as find new ways to improve longevity
and physical well being.
To know more, click on
the link below:
Related Report:
Contact Us:
Ken Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment